TerminatedPhase 3NCT03002012
Cryptococcal Antigen Screening Plus Sertraline
Studying Cryptococcosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Minnesota
- Principal Investigator
- Elizabeth K Nalintya, MBChB MPHInfectious Disease Institute
- Intervention
- Sertraline(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2018
Study locations (1)
- Infectious Disease Institute, Makerere University, Kampala, Uganda
Collaborators
Infectious Diseases Institute, Uganda · National Institute of Allergy and Infectious Diseases (NIAID) · Mbarara University of Science and Technology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03002012 on ClinicalTrials.govOther trials for Cryptococcosis
Additional recruiting or active studies for the same condition.